News

Abeona Therapeutics' pz-cel gene therapy shows the most durable wound healing in RDEB patients. See why I rate ABEO stock a ...
Abeona Therapeutics faces a pivotal FDA decision after a CRL-led crash and partial rebound in pz-cel’s valuation. Check out ...
Baby Abeo is finally in the arms of his forever gorilla mom. Driving the news: The zoo announced that Abeo, which means "bringer of happiness", was successfully introduced to 40-year-old foster ...
Shares of NASDAQ ABEO opened at $5.12 on Monday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 6.12 and a current ratio of 6.12. The stock has a 50 day moving average price of ...
CLEVELAND, April 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity ...
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call Transcript March 20, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.24, expectations were $-0.43.
NASDAQ ABEO opened at $5.12 on Monday. Abeona Therapeutics has a 52 week low of $3.05 and a 52 week high of $8.45. The company has a 50 day moving average price of $5.43 and a 200 day moving ...
Stifel resumed coverage of Abeona Therapeutics (ABEO) with a Buy rating and $14 price target While acknowledging both the difficult-to-vet ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...